Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
7.38
-0.59 (-7.40%)
Nov 20, 2024, 4:00 PM EST - Market closed
Addex Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 7 | 7 | 11 | 43 | 60 | 45 | |
| Market Cap Growth | -48.81% | -34.64% | -74.03% | -28.14% | 34.18% | -25.63% | |
| Enterprise Value | 2 | 2 | 0 | 27 | 40 | 7 | |
| Last Close Price | 7.38 | 6.05 | 12.60 | 125.80 | 268.00 | - | |
| PS Ratio | 6.72 | 3.75 | 7.19 | 12.50 | 13.72 | 15.33 | |
| PB Ratio | 0.46 | 5.40 | 2.11 | 2.33 | 3.64 | 1.70 | |
| P/TBV Ratio | 0.46 | 5.40 | 2.11 | 2.33 | 3.64 | 1.70 | |
| EV/Sales Ratio | 2.50 | 1.06 | 0.28 | 7.76 | 9.20 | 2.50 | |
| Debt / Equity Ratio | 0.00 | 0.30 | 0.08 | 0.03 | 0.04 | 0.02 | |
| Asset Turnover | 0.08 | 0.25 | 0.09 | 0.15 | 0.15 | 0.08 | |
| Quick Ratio | 4.67 | 1.39 | 2.30 | 5.03 | 5.18 | 5.57 | |
| Current Ratio | 4.97 | 1.46 | 2.39 | 5.31 | 5.38 | 5.70 | |
| Return on Equity (ROE) | -126.29% | -348.48% | -190.48% | -97.35% | -64.08% | -45.64% | |
| Return on Assets (ROA) | -61.71% | -99.44% | -83.22% | -45.37% | -28.76% | -24.26% | |
| Return on Capital (ROIC) | -73.55% | -189.67% | -113.00% | -59.47% | -37.10% | -27.95% | |
| Earnings Yield | 72.37% | -170.78% | -200.32% | -38.95% | -24.15% | -34.03% | |
| FCF Yield | -133.45% | -129.41% | -158.28% | -37.38% | -22.99% | -21.90% | |
| Buyback Yield / Dilution | -50.83% | -64.45% | -32.43% | -27.88% | -0.96% | -13.46% | |
| Total Shareholder Return | -50.83% | -64.45% | -32.43% | -27.88% | -0.96% | -13.46% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.